Benzinga's Top Downgrades
September 18, 2013 at 07:40 AM EDT
Analysts at Bank of America downgraded ViroPharma (NASDAQ: VPHM ) from “neutral” to “underperform.” The target price for ViroPharma is set to $34. ViroPharma's shares closed at $40.78 yesterday. Morgan Stanley downgraded Intuit (NASDAQ: INTU ) from “equal-weight” to “underweight.” The target price for Intuit is set to